Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 20,000 shares (grant or award)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Grant or award Director acquired 20,000 shares (grant or award)
  4. 4 Grant or award Director acquired 20,000 shares (grant or award)
  5. 4 Shares withheld for taxes President & CBO gave up 3,358 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Executive Officer gave up 11,315 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, R&D and CMO gave up 2,659 shares (to pay taxes)
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations · Regulation FD disclosure
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 8-K/A Event Exhibits
  12. 8-K/A Event Other events
  13. 8-K Event Other events
  14. 424B5 Offering Prospectus
  15. 8-K Event Regulation FD disclosure · Other events
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 19,200 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 8 of 80 · 1,583 filings